industrious
发表于 2025-3-21 17:14:19
书目名称Clinical Cancer Prevention影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0227830<br><br> <br><br>书目名称Clinical Cancer Prevention影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0227830<br><br> <br><br>书目名称Clinical Cancer Prevention网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0227830<br><br> <br><br>书目名称Clinical Cancer Prevention网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0227830<br><br> <br><br>书目名称Clinical Cancer Prevention被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0227830<br><br> <br><br>书目名称Clinical Cancer Prevention被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0227830<br><br> <br><br>书目名称Clinical Cancer Prevention年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0227830<br><br> <br><br>书目名称Clinical Cancer Prevention年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0227830<br><br> <br><br>书目名称Clinical Cancer Prevention读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0227830<br><br> <br><br>书目名称Clinical Cancer Prevention读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0227830<br><br> <br><br>
妨碍
发表于 2025-3-21 23:08:58
https://doi.org/10.1007/978-3-642-10858-7Cancer chemoprevention; Cancer prevention; Prevention of breast cancer; Prevention of prostate cancer
新娘
发表于 2025-3-22 00:48:21
http://reply.papertrans.cn/23/2279/227830/227830_3.png
卵石
发表于 2025-3-22 04:50:08
Hans-Jörg Senn,Florian OttoWritten by some of the world’s leading experts, whose fields include genetics and microbiology, epidemiology, and health economics, as well as clinical cancer prevention.Presents the latest advances i
袖章
发表于 2025-3-22 12:18:16
http://reply.papertrans.cn/23/2279/227830/227830_5.png
amorphous
发表于 2025-3-22 16:01:12
0080-0015 of the contributors encompasses genetics and microbiology, epidemiology, and health economics, as well as clinical cancer prevention. This book will be of interest to all who wish to learn about the most recent progress in combating the development of cancer.978-3-642-26568-6978-3-642-10858-7Series ISSN 0080-0015 Series E-ISSN 2197-6767
amorphous
发表于 2025-3-22 19:58:26
http://reply.papertrans.cn/23/2279/227830/227830_7.png
Discrete
发表于 2025-3-22 22:25:18
Lessons Learned from Prevention Programs: Different Endpoints Should Be Used in Secondary and Terti
Countermand
发表于 2025-3-23 05:21:52
Biomarkers for Early Detection and as Surrogate Endpoints in Cancer Prevention Trials: Issues and O
衰老
发表于 2025-3-23 09:16:03
http://reply.papertrans.cn/23/2279/227830/227830_10.png